Moderna Announces Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update
Go back to Moderna Announces Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 155.04 -3.03 (1.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $158.07 | 52 Week High | $0.52 | |||
| Open | $158.36 | 52 Week Low | $0.08 | |||
| Day High | $159.79 | P/E | N/A | |||
| Day Low | $153.80 | EPS | $-3.80 | |||
| Volume | 4,050,465 | |||||
